Breaking Health

Pear Therapeutics CEO Corey McCann, MD, PhD delves into the potential digital therapeutics have in helping people who abuse drugs and alcohol. The company’s product pipeline includes potential treatment for schizophrenia, combat-PTSD, generalized anxiety disorder, insomnia and traumatic brain injury.

OnShift CEO Mark Woodka knows better management of health care professionals can improve care. And he practices what he preaches, explaining how HR also is essential to a start-up.

Behavioral health isn’t always seen as an integral part of health care, but Care Management Technologies is breaking down those walls.

On this week’s installment of Breaking Health, Host Steve Krupa – CEO of the Psilos Group – dives into the intriguing story behind SolveBio, a company working to disrupt precision medicine.In this interview, Mark Kaganovich, PhD, CEO, and co-founder, discusses the benefits of SolveBio’s innovative data layer – called the “Genomic Intelligence Platform” – aimed at enabling pharma, biotech, and diagnostic organizations to effectively interact with genomic information.Founded in 2013 by graduate school classmates David Caplan, David Gross, and Kaganovich, SolveBio recognizes that isolated DNA sequencing technology has become increasingly essential in medicine and health care. But the process lacks accessible reference data that compares and cross references results from similar clinical trials, studies, and cases that may help decided company strategy or patient care. Kaganovich says the lack of context in genomics studies can sometimes be “mind boggling.”“This hasn’t really fully played out yet, but you’ll have people that make life-altering decisions based on a diagnostic report, and that report, where is the reference data for that? How do you know if you have a pathogenic variance or a benign variance?” Kaganovich asks. “It comes from some reference data set somewhere that probably some grad student contributed to some FTP site, and that kind of sat there. And then it was parsed out by a bioinformatician. It was normalized and some kind of quality control was done. But in the end, it comes from research often, or people don’t even know where it comes from. And to me, that’s kind of scary.”Where is SolveBio now? Dive with us into the episode here to learn in more detail about what the wider applications to SolveBio's mission could mean for health care tech and population care, and how its in-depth knowledge hub has already helped well-known customers.

People enduring chronic stress are less likely to eat right, exercise, sleep enough, or do many of the basic things necessary for good health, says Jan Bruce, co-founder of meQuilibrium. The answer, of course, is simple. Find ways to reduce stress, but the path to a less stressful existence isn’t as clear as it might be. Bruce co-founded meQuilibrium to deliver individualized plans for employees designed to help them build “resilience” to stress. Psilos CEO Steve Krupa and Bruce delve into the actual impacts stress is having on health and the economy.Guest Bio:Jan Bruce has devoted much of the last twenty years to pioneering new brands in health, wellness, consumer lifestyle, and holistic medicine. She has a passion for building strong business strategies and cohesive management teams that deliver results. She is widely recognized as an authority on women’s attitudes toward a balanced healthy lifestyle and sustainable living. She also regularly speaks on business turnarounds and LOHAS business issues. In 2004 Bruce sold her company, body+soul/whole living, to Martha Stewart Living Omnimedia and then served as her former firm’s managing director for five years, during which time she led the growth of the business: quadrupling the revenues and tripling the circulation, spawning a multi‐platform franchise that includes website, video on demand, a daily radio show, and a new green cleaning product‐line. She then co-founded meQuilibrium after having a surprising personal epiphany that stress was keeping her from enjoying the rewards of her work.